NCT00679770View on ClinicalTrials.gov

Study of Different Doses of a Novel Treatment for Onychomycosis

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Distal, Subungual Onychomycosis
Interventions
DRUG

AN2690, 2.5%

Once daily application for 90 days and 3 x weekly for 90 days

DRUG

AN2690, 5%

Once daily application for 90 days and 3 x weekly for 90 days

DRUG

AN2690, 7.5%

Once daily application for 90 days and 3 x weekly for 90 days

DRUG

Vehicle

Once daily application for 90 days and 3x weekly for 90 days

Trial Locations (4)

77802

J&S Studies, Bryan

78229

Endeavor Clinical Trials, PA & San Antonio Podiatry Associates, PC, San Antonio

78759

DermResearch, Inc., Austin

87106

Academic Dermatology Associates, Albuquerque

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00679770 - Study of Different Doses of a Novel Treatment for Onychomycosis | Biotech Hunter | Biotech Hunter